Clinical Trials Browser

Phase 2 × Interventional × Progression-Free Survival × Clear all

NCT06826092 2025-02-13

Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

Phase 2 Recruiting

Progression-Free Survival